Sandoz Says Feds Misclassified Generics As 'Innovator Drugs' - Law360

Sandoz Says Feds Misclassified Generics As ‘Innovator Drugs’ – Law360

Source Node: 2543069
By Henrik Nilsson (April 11, 2024, 10:47 PM EDT) — Pharmaceutical company Sandoz Inc. sued the Centers for Medicare & Medicaid Services in Washington, D.C., federal court on Wednesday, alleging the agency ignored the company’s objection to classifying two of its generics as “innovator drugs,” which could impact Sandoz’s rebate obligations under Medicaid….

Time Stamp:

More from Law 360